Therapeuticsmd Inc (TXMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2011 | |
| Cash Flows From Operating Activities | |
| Net Income | -774 |
| Depreciation Amortization | 14 |
| Accounts receivable | -12 |
| Accounts payable and accrued liabilities | 4 |
| Other Working Capital | -55 |
| Other Operating Activity | 63 |
| Operating Cash Flow | $-761 |
| Cash Flows From Investing Activities | |
| PPE Investments | -11 |
| Investing Cash Flow | $-11 |
| Cash Flows From Financing Activities | |
| Debt Issued | 267 |
| Common Stock Issued | 100 |
| Financing Cash Flow | $367 |
| Beginning Cash Position | 423 |
| End Cash Position | 19 |
| Net Cash Flow | $-404 |
| Free Cash Flow | |
| Operating Cash Flow | -761 |
| Capital Expenditure | -11 |
| Free Cash Flow | -772 |